Background The replication-competent recombinant vesicular stomatitis virus (rVSV)–based
vaccine expressing a Zaire ebolavirus (ZEBOV) glycoprotein was selected for rapid safety …

A highly protective malaria vaccine would greatly facilitate the prevention and elimination of
malaria and containment of drug-resistant parasites 1 . A high level (more than 90%) of …

Antibodies can protect from Plasmodium falciparum (Pf) infection and clinical malaria
disease. However, in the absence of constant reexposure, serum immunoglobulin (Ig) levels …

Sanaria Inc. has developed methods to manufacture, purify and cryopreserve aseptic Plasmodium
falciparum (Pf) sporozoites (SPZ), and is using this platform technology to develop an …

Acute and chronic Plasmodium falciparum malaria are accompanied by severe immunodepression
possibly related to subversion of dendritic cells (DC) functionality. Phagocytosed …

Background The quartan malaria parasite Plasmodium malariae is the widest spread and
best adapted human malaria parasite. The simian Plasmodium brasilianum causes quartan …

A point mutation in the promoter of the nitric oxide synthase 2 gene (NOS2), termed NOS2
Lambaréné (NOS2‐G954C), protects heterozygous carriers against severe malaria as …

Controlled human infection (CHI) trials, in which healthy volunteers are experimentally infected,
can accelerate the development of novel drugs and vaccines for infectious diseases of …

Malaria is a major public health problem in Sub-Saharan Africa. In highly endemic regions
infants, children and pregnant women are mostly affected. An effective malaria vaccine would …

Affinity maturation, the clonal selection and expansion of antigen-activated B cells expressing
somatically mutated antibody variants that develop during T cell–dependent germinal …